Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
05/2012
05/30/2012EP2324112B1 Mutant pestivirus with mutations in core gene and ns3 region
05/30/2012CN102482647A Production of polio virus at high titers for vaccine production
05/30/2012CN102482328A 包含血凝素的嵌合流感病毒样颗粒 Chimeric influenza virus-like particles containing the hemagglutinin
05/30/2012CN102481378A Hpv颗粒及其用途 Hpv particles and their use
05/30/2012CN102477092A 控制花青素含量的蛋白及其编码基因与应用 Protein coding gene and application control anthocyanin content
05/30/2012CN102477091A 水稻雄性不育蛋白及其编码基因与应用 Male sterility in rice protein and its encoding gene and application
05/30/2012CN102477090A 促进叶绿体发育的蛋白及其编码基因与应用 Promoting protein and its encoding gene and application of chloroplast development
05/30/2012CN101947317B Large-scale preparation method of H5N1 avian influenza virus-like particle vaccines
05/30/2012CN101792740B Recombinant baculovirus expressing Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) immunogen gene and preparation method and application thereof
05/30/2012CN101591646B Dendritic cell vaccine for treating human cervical carcinoma
05/30/2012CN101100657B Method for large scale production of virus antigen
05/29/2012CA2478616C Use of adenoviruses mutated in the va genes for cancer treatment
05/29/2012CA2469623C Composition for the preservation of viruses
05/29/2012CA2408786C Retroviral vectors comprising an enhanced 3' transcription termination structure
05/24/2012WO2012066481A1 New ethiological agent
05/24/2012WO2012024351A3 Adenoviral assembly method
05/24/2012WO2011064630A8 New clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer
05/24/2012US20120129710 Methods for producing members of specific binding pairs
05/24/2012US20120129263 Recombinant viral vector for gene transfer into lymphoid cells
05/24/2012US20120129154 Methods and compositions for the detection of bacterial blight
05/24/2012US20120128713 Replication-Defective Flavivirus Vaccine Vectors Against Respiratory Syncytial Virus
05/24/2012CA2818353A1 Methods and compositions for inducing an immune response to egfrviii
05/24/2012CA2817933A1 New ethiological agent
05/23/2012EP2455390A1 Hepatitis B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
05/23/2012EP2454364A1 Production of polio virus at high titers for vaccine production
05/23/2012EP2453917A1 A composition useful as rotavirus vaccine and a method therefor.
05/23/2012EP1847596B1 Method of retrovirus storage
05/23/2012CN102471300A 用于增强病毒效力的组合物和方法 Compositions and methods for enhancing the effectiveness of the virus
05/23/2012CN102470170A Composition useful as rotavirus vaccine and a method therefor
05/23/2012CN102465144A 柯萨奇病毒a16型病毒样颗粒疫苗 Coxsackie virus-like particle vaccine a16
05/23/2012CN102465137A 表达轮状病毒类表达颗粒的毕赤酵母、其制备方法及用途 Rotavirus class expression Pichia expression particles, their preparation and use
05/23/2012CN102465117A Chimeric simian/human immunodeficency virus strain and application thereof
05/23/2012CN102465110A Cell lysis device and methods of lysing cells or viruses
05/23/2012CN102038945B Method for industrially producing swine parvovirus vaccine by utilizing bioreactor
05/23/2012CN101899466B Dengue virus and Japanese encephalitis virus embedded pseudo virus particle vaccine and preparation method thereof
05/23/2012CN101775373B Method for activating frozen virus source of rice black-streaked dwarf virus
05/23/2012CN101696398B Equine infectious anemia virus pathopoiesia virulent strain ass fetus skin cell adapted strain and application
05/23/2012CN101665781B High-titer Porcine circovirus 2-type cultured cell, preparation method and use thereof
05/23/2012CN101624581B Pseudovirus based on Vasohibin gene and preparation method and application thereof
05/22/2012US8183356 Lentiviral packaging constructs
05/22/2012US8183352 Attenuated vif DNA immunization cassettes for genetic vaccines
05/22/2012US8183030 Saccharomyces cerevisiae receptor proteins; fusion proteins
05/22/2012US8183025 Solenopsis invicta virus
05/22/2012CA2596292C Vectors and viral vectors, and packaging cell lines for propagating same
05/22/2012CA2456169C Methods and compositions relating to improved lentiviral vector production systems
05/22/2012CA2449013C Viral mutants that selectively replicate in targeted human cancer cells
05/18/2012WO2012064660A1 Recombinant p4 bacteriophage and methods for their use
05/18/2012WO2012063212A1 North american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
05/18/2012CA2817486A1 North american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof
05/18/2012CA2816334A1 Recombinant p4 bacteriophage and methods for their use
05/17/2012US20120122963 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
05/17/2012US20120122204 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
05/17/2012US20120122186 Novel bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus enterococcus
05/17/2012US20120122185 Chimeric viruses presenting non-native surface proteins and uses thereof
05/17/2012US20120122177 Viral Infection Enhancing Peptide
05/17/2012US20120122155 Immortalized avian cell lines and use thereof
05/17/2012US20120122138 Consumable component kit
05/17/2012US20120121650 Chimeric Virus Vaccines
05/17/2012US20120121629 New human rotavirus vaccine strains and diagnostics
05/17/2012US20120121614 Methods and compositions for bi-specific targeting of cd19/cd22
05/16/2012EP2451945A1 Oncolytic viruses and methods for treating neoplastic disorders
05/16/2012EP2451827A1 Chimaeric protein
05/16/2012EP2451795A1 Compositions and methods for enhancing virus efficacy
05/16/2012EP1973931B1 Chicken virus vaccine and diagnostic
05/16/2012CN102459578A 基于在北美狗中循环的犬瘟热病毒的免疫原性组合物、疫苗和诊断方法 The immunogenic composition based on the North American dog distemper virus circulating, and vaccines and diagnostic methods
05/16/2012CN102458427A Combined measles-malaria vaccine
05/16/2012CN102453711A Establishment of protein secreted expression vector and application of same
05/16/2012CN102453701A Gene modified CDR3 delta transplanted gamma delta T lymphocyte and its antitumor purpose
05/15/2012US8178657 Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins
05/15/2012US8178111 GM-negative EHV-mutants without heterologous elements
05/15/2012US8178087 Process of production of bacteriophage compositions and methods in phage therapy field
05/15/2012CA2516581C Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination
05/15/2012CA2439452C High-affinity antagonists of elr-cxc chemokines
05/10/2012WO2012061637A2 Hsv-1 epitopes and methods for using same
05/10/2012WO2012059696A1 Method for improving the production of influenza viruses and vaccine seeds
05/10/2012WO2012058762A1 Plant expression system
05/10/2012WO2011125054A3 Protein and nucleic acid delivery vehicles, components and mechanisms thereof
05/10/2012US20120117674 Method for generating replication defective viral vectors that are helper free
05/10/2012US20120117673 Genetic encryption
05/10/2012US20120115207 Enhanced production of papillomavirus-like particles with a modified baculovirus expression system
05/10/2012US20120115206 Non-tumorigenic mdck cell line for propagating viruses
05/10/2012US20120115204 Virus filtration of liquid factor vii compositions
05/10/2012US20120114694 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
05/10/2012US20120114691 Vaccine against african horse sickness virus
05/10/2012US20120114619 Protein with promoting effects for axonal growth of neurons of central nervous system
05/10/2012US20120114612 Oncolytic Viruses And Methods For Treating Neoplastic Disorders
05/10/2012CA2854619A1 Methods for producing virus particles with simplified glycosylation of surface proteins
05/10/2012CA2826234A1 Novel vaccines against the a/h1n1 pandemic flu virus
05/10/2012CA2816838A1 Method for improving the production of influenza viruses and vaccine seeds
05/10/2012CA2815887A1 Plant expression system
05/09/2012EP2449096A1 A method of preparation of a biological particulate structure
05/09/2012EP2448598A1 Swine influenza hemagglutinin variants
05/09/2012EP1660686B1 Hpv cd8+ t-cell epitopes
05/09/2012CN1826406B Production of poxviruses with adherent or non adherent avian cell lines
05/09/2012CN102443594A Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application
05/09/2012CN102443576A Mutant of endoglucanase, coding gene and application thereof
05/09/2012CN102443572A Method for purifying detoxified pertussis vaccine antigen solution
05/09/2012CN102443571A Chicken-origin H9N2 avian influenza virus strain and application thereof
05/09/2012CN102443063A Anti-TNFalpha humanized Fab, humanized antibody and its application
05/09/2012CN101880651B Preparation method of Muscovy duck parvo novel vaccines
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 267